查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1465048

耳鼻喉科疾病治療市場：按治療類型、疾病類型、最終用戶分類 - 全球預測 2024-2030

ENT Disorder Treatment Market by Treatment Type (Device, Drugs), Disorder Type (Ear, Nose, Throat), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年耳鼻喉疾病治療市場規模為253.4億美元，2024年達268.3億美元，預計2030年將達387.7億美元，複合年成長率為6.26%。

耳鼻喉科疾病治療涉及對影響耳、鼻、喉及相關頭頸結構的疾病進行全面的醫療和外科治療。這些疾病的範圍從鼻竇感染疾病和聽力損失等常見問題到咽喉癌和腦神經疾病等複雜疾病。治療對於緩解症狀、改善生活品質和預防可能導致更嚴重健康風險的併發症至關重要。由於污染導致的過敏反應和呼吸道疾病的盛行率不斷上升，推動了對耳鼻喉科疾病治療的需求。此外，隨著世界老化，人們變得更容易患慢性耳鼻喉疾病，如聽力損失和鼻竇。這些人口變化正在推動對增強耳鼻喉科治療解決方案的需求，以滿足老年患者的獨特需求。然而，與耳鼻喉科藥物和藥品相關的嚴格法規和耗時的核准給主要企業帶來了重大挑戰。公司經常致力於引入新的治療方法，以在這種環境下保持敏捷。此外，醫療設備和治療方法的技術創新顯著提高了耳鼻喉科治療的效果和效率。微創手術和雷射治療等技術創新正在擴大患者的治療選擇，並促進市場成長。

主要市場統計
基準年[2023] 253.4億美元
預測年份 [2024] 268.3億美元
預測年份 [2030] 387.7億美元
複合年成長率（%） 6.26%

治療類型 使用耳鼻喉科設備和耳鼻喉科藥物治療嚴重的耳鼻喉科疾病

醫療設備的進步顯著提高了耳鼻喉科疾病患者的生活品質。人工電子耳是一種革命性的設備，可為嚴重聽力損失的人提供聲音的感覺。持續性呼吸道陽壓呼吸器(CPAP) 機是阻塞型睡眠呼吸中止症患者的重要治療方法，可在睡眠時保持呼吸道通暢。助聽器還可以為聽力損失的人放大聲音，鼻夾板用於支撐鼻結構並幫助手術或鼻外傷後的正常癒合。同時，藥物治療在耳鼻喉科疾病的管理和治療中發揮重要作用。發炎藥物可以減輕耳、鼻、喉的發炎，有助於緩解疼痛和減輕腫脹。抗生素用於對抗細菌感染，對於細菌性鼻竇和外耳炎等疾病至關重要。抗組織胺有效抑制過敏反應症狀，緩解鼻塞、打噴嚏等過敏相關症狀。此外，類固醇因其強大的發炎特性而被使用，並且經常在耳鼻喉科領域用於治療嚴重的發炎和過敏反應病例。

最終用戶：醫院和門診手術中心擴大使用耳鼻喉科設備，在提供優質醫療服務的同時提供專業護理。

門診手術中心已成為患者的便捷選擇，並透過提供當天的手術治療（包括診斷和預防程序）提供住院治療的有效替代方案。耳鼻喉科診所在提供耳鼻喉疾病的專業治療、促進早期診斷和根據患者個別需求制定治療計劃方面發揮著至關重要的作用。醫院是治療鏈的基本組成部分，擁有先進技術和多學科團隊的支持，並有能力治療從輕微到複雜的頻譜耳鼻喉疾病。同時，專科診所提供特定耳鼻喉科領域的專業知識，由該領域的專家提供優質護理和創新治療。每個最終使用者在提供適當的護理和改善耳鼻喉科疾病患者的生活品質方面都發揮著重要作用。

區域洞察

在美洲，耳鼻喉科疾病的日益普及和醫療基礎設施的改善正在推動市場的顯著成長。消費者的高度意識和投資先進治療（包括微創手術）的意願正在推動該地區的創新。最近的專利主要集中在新的診斷工具和標靶治療。該地區的公共和私人投資正在推動研究舉措，特別是在生技藥品和精準醫學領域。同時，歐洲、中東和非洲地區得到完善的醫療保健系統的支持，並表現出對耳鼻喉科治療研究和創新的堅定承諾。臨床試驗和研發的跨境合作在該地區很常見，為新的治療方法和設備鋪平了道路。監管支持也促進了針對不同患者群體的新解決方案進入市場。由於耳鼻喉科相關疾病的增加、人口老化以及醫療基礎設施的改善，亞太地區的耳鼻喉科治療市場正在經歷顯著成長。在中國、印度等人口眾多的國家，由於污染、不良生活習慣、遺傳性疾病等因素，對耳鼻喉科治療的需求不斷增加。該地區大型製藥公司和新興本地公司大力投資研發更有效、更實惠的治療方法，也推動了市場的發展。

FPNV定位矩陣

FPNV定位矩陣對於評估耳鼻喉科市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對耳鼻喉科市場供應商的現狀進行富有洞察力和深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.耳鼻喉科治療市場的市場規模與預測是多少？

2.耳鼻喉科市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.耳鼻喉科治療市場的技術趨勢和法規結構是什麼？

4.耳鼻喉科市場主要廠商的市場佔有率是多少？

5.進入耳鼻喉科疾病治療市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個體耳、鼻、喉過敏原增加
      • 世界各地的人口正在老化，這增加了對慢性耳鼻喉疾病和聽力損失的侵入性治療的需求。
      • 隨著數位化和家庭耳鼻喉科診斷的引入
    • 抑制因素
      • 耳鼻喉科藥品及器材核准嚴格規定
    • 機會
      • 耳鼻喉科疾病診斷與治療技術的進步
      • 對耳鼻喉科相關疾病的有利政府措施和財政支持
    • 任務
      • 發展中地區對耳鼻喉科疾病及治療方法缺乏認知
  • 市場區隔分析
    • 治療類型：使用耳鼻喉儀器及耳鼻喉藥治療嚴重耳鼻喉疾病
    • 最終使用者：醫院和門診手術中心擴大使用耳鼻喉設備來提供高品質的護理，同時提供專業護理。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章依治療類型分類的耳鼻喉疾病治療市場

  • 裝置
  • 藥物

第7章依障礙類型分類的耳鼻喉科疾病治療市場

  • 耳朵
  • 鼻子
  • 喉

第8章 耳鼻喉科疾病治療市場：依最終使用者分類

  • 門診手術中心
  • 耳鼻喉科診所
  • 醫院
  • 專科診所

第9章 北美及南美耳鼻喉科市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太耳鼻喉科疾病治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲耳鼻喉科治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Integra (IART) 透過新的收購交易推動耳鼻喉科業務
    • Fifth Sense 與英國耳鼻喉科宣佈建立策略夥伴關係，以改善對嗅覺和味覺障礙患者的護理
    • Oto 和 Lindus Health 啟動遠端試驗，以改善患者獲得耳鳴治療的機會
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-757B1C9CAFAB

[186 Pages Report] The ENT Disorder Treatment Market size was estimated at USD 25.34 billion in 2023 and expected to reach USD 26.83 billion in 2024, at a CAGR 6.26% to reach USD 38.77 billion by 2030.

ENT disorder treatment encompasses the comprehensive medical and surgical management of conditions affecting the ear, nose, and throat, along with related head and neck structures. These disorders can range from common issues, such as sinus infections and hearing loss, to more complex conditions, like throat cancer or cranial nerve disorders. The treatment is vital for alleviating symptoms, improving quality of life, and preventing complications leading to more severe health risks. The rising prevalence of allergic reactions and respiratory ailments due to pollution has boosted the demand for ENT disorder treatment. In addition, the growing aging population worldwide is more prone to chronic ENT disorders, such as hearing loss and sinusitis. This demographic shift is driving the demand for enhanced ENT treatment solutions to cater to the unique needs of elderly patients. However, the strict regulations associated with ENT drugs and medicine and their lengthy approvals present a significant challenge for the key players. Companies frequently work towards introducing a novel treatment option to remain agile within the landscape. Moreover, technological innovations in medical devices and treatment methods have greatly enhanced the efficacy and efficiency of ENT treatments. Innovations such as minimally invasive surgery and laser treatments have expanded patient treatment options, contributing to market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 25.34 billion
Estimated Year [2024] USD 26.83 billion
Forecast Year [2030] USD 38.77 billion
CAGR (%) 6.26%

Treatment Type: Utilization of ENT devices and ENT medications to cater severe ENT conditions

The advancement in medical devices has significantly improved the quality of life for individuals with ENT disorders. Cochlear implants are revolutionary devices that provide a sense of sound to the profoundly deaf and severely hard of hearing. Continuous positive airway pressure (CPAP) devices are a cornerstone treatment for patients with obstructive sleep apnea, ensuring the airway remains open during sleep. In addition, hearing aids amplify sound for individuals with hearing loss, while nasal splints are used post-surgery or after nasal trauma to support the nose structure and aid in proper healing. On the other hand, medications play a crucial role in managing and treating ENT disorders. Anti-inflammatory drugs help reduce inflammation in the ear, nose, and throat, leading to pain relief and reduced swelling. Antibiotics are prescribed to combat bacterial infections, crucial in conditions such as bacterial sinusitis or ear infections. Antihistamines effectively control allergic reaction symptoms, thereby alleviating nasal congestion, sneezing, and other allergy-related symptoms. Moreover, steroids are used for their potent anti-inflammatory properties, often prescribed for severe cases of inflammation or allergic reactions in the ENT region.

End-User: Increasing usage of ENT devices in hospitals & ambulatory surgical centers offering specialized care while delivering high-quality care

Ambulatory surgical centers have emerged as a convenient option for patients, offering same-day surgical care, including diagnostic and preventive procedures, which is an efficient alternative to hospital admissions. ENT clinics play a pivotal role, providing specialized care focusing on ear, nose, and throat conditions, facilitating early diagnosis and treatment plans tailored to individual patient needs. Hospitals represent a fundamental component of the treatment chain, equipped to handle a comprehensive spectrum of ENT disorders, from mild to complex cases, supported by advanced technologies and multidisciplinary teams. At the same time, specialty clinics offer focused expertise in specific ENT areas, delivering high-quality care and innovative treatments driven by specialists in the field. Each end-user plays a vital role in providing adequate care and enhancing the quality of life for patients with ENT disorders.

Regional Insights

In the Americas, an increasing prevalence of ENT disorders and a robust healthcare infrastructure spurs significant market growth. High consumer awareness and willingness to invest in advanced treatments, including minimally invasive surgeries, drive innovation in this region. Recent patents emphasize novel diagnostic tools and targeted therapies. The region's public and private sector investments fuel research initiatives, notably in biologics and precision medicine. On the other hand, EMEA demonstrates a strong commitment to research and innovation in ENT treatments, buoyed by its well-established healthcare systems. Cross-border collaborations for clinical trials and R&D are common in the region, paving the way for novel therapies and devices. Regulatory support further facilitates market access for new solutions, catering to a diverse patient population. The Asia Pacific region is witnessing significant growth in the ENT disorder treatment market, driven by rising incidences of ENT-related diseases, an aging population, and improvements in healthcare infrastructure. Countries such as China and India, with their large populations, are seeing an increase in the demand for ENT treatments due to factors including pollution, poor lifestyle choices, and genetic conditions. The presence of significant pharmaceutical companies and emerging local players in the region investing heavily in R&D for more effective and affordable treatments is also propelling the market forward.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ENT Disorder Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ENT Disorder Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ENT Disorder Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ALK-Abello AS, Apikos Pharma, AstraZeneca PLC, Bayer AG, Cipla Limited, Covis Pharma BV, Dr. Reddy's Laboratories, F. Hoffmann-La Roche AG, Fennec Pharmaceuticals Inc., GlaxoSmithKline PLC, Integra Lifesciences Corporation, Integra Lifesciences CorporationAbbVie Inc., Intersect ENT, Inc. by Medtronic PLC, Johnson & Johnson Services, Inc., Karl Storz, Merck & Co., Inc., Novartis AG, Olympus Corporation, OptiNose US, Inc., Pfizer Inc., Sanofi SA, Sensorion SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Vitaris Inc..

Market Segmentation & Coverage

This research report categorizes the ENT Disorder Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Device
      • Cochlear Implants
      • Continuous Positive Airway Pressure Devices
      • Hearing Aids
      • Nasal Splints
    • Drugs
      • Anti-inflammatory Drugs
      • Antibiotics
      • Antihistamines
      • Steroids
  • Disorder Type
    • Ear
      • Meniere's Disease
      • Otitis Externa
      • Otitis Media
      • Otomycosis
    • Nose
      • Nasal Polyps
      • Rhinitis
      • Sinusitis
    • Throat
      • Pharyngitis
      • Tonsillitis
      • Tonsillopharyngitis
  • End-User
    • Ambulatory Surgical Centers
    • ENT Clinics
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the ENT Disorder Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ENT Disorder Treatment Market?

3. What are the technology trends and regulatory frameworks in the ENT Disorder Treatment Market?

4. What is the market share of the leading vendors in the ENT Disorder Treatment Market?

5. Which modes and strategic moves are suitable for entering the ENT Disorder Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The rising prevalence of ear, nose, and throat allergens among individuals
      • 5.1.1.2. The growing aging population worldwide and the need of invasive care for chronic ENT disorders and hearing loss
      • 5.1.1.3. Owing adoption of digital and home-based ENT diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations associated with the approval of ENT drugs and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the diagnostic and treatment procedures of ENT disorder
      • 5.1.3.2. Favorable government initiatives and funding for ENT-related diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Insufficient awareness about ENT disorders and available treatments in underdeveloped regions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Type: Utilization of ENT devices and ENT medications to cater severe ENT conditions
    • 5.2.2. End-User: Increasing usage of ENT devices in hospitals & ambulatory surgical centers offering specialized care while delivering high-quality care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. ENT Disorder Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Device
  • 6.3. Drugs

7. ENT Disorder Treatment Market, by Disorder Type

  • 7.1. Introduction
  • 7.2. Ear
  • 7.3. Nose
  • 7.4. Throat

8. ENT Disorder Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. ENT Clinics
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas ENT Disorder Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ENT Disorder Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ENT Disorder Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Integra (IART) to Advance ENT Division with New Buyout Deal
    • 12.3.2. Fifth Sense and ENT UK Announce Strategic Partnership to Improve Care for People Affected by Smell and Taste Disorders
    • 12.3.3. Oto and Lindus Health Launch a Remote Trial to Increase Patient Access to Tinnitus Therapy
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ENT DISORDER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ENT DISORDER TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENT DISORDER TREATMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ENT DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. ENT DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENT DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HEARING AIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HEARING AIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL SPLINTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL SPLINTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY MENIERE'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY MENIERE'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS EXTERNA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS EXTERNA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTOMYCOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTOMYCOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL POLYPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL POLYPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SINUSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SINUSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY PHARYNGITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY PHARYNGITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLOPHARYNGITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLOPHARYNGITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ENT CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 133. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 139. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 140. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 147. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 148. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 149. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 153. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 154. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 155. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 156. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 157. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 163. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 164. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 165. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 171. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 172. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 173. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 176. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 198. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 199. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 200. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 204. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 206. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 208. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 214. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 215. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 216. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 217. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 220. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 221. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 222. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 223. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 224. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 225. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 230. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 231. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 232. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 233. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 236. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 237. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 238. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 239. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 240. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 241. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 246. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 247. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 248. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 249. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 252. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 253. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 254. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 255. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 256. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 257. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 262. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 263. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 264. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 265. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 268. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 269. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 270. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 271. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 272. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 273. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 278. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 279. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 280. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 281. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 284. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 285. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 286. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 287. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 288. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 289. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 294. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 295. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 296. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 297. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 300. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 302. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 304. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 310. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 311. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 312. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 313. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 316. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 317. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 318. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 319. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 320. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 321. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
  • TABLE 337. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
  • TABLE 342. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
  • TABLE 343. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 344. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 345. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
  • TABLE 348. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)

T